Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
113.42
-0.59 (-0.52%)
Oct 1, 2024, 1:17 PM EDT - Market open
Abbott Laboratories Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Abbott Laboratories stock have an average target of 124.91, with a low estimate of 107 and a high estimate of 143. The average target predicts an increase of 10.13% from the current stock price of 113.42.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ABT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 3 | 3 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 9 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $120 → $124 | Buy | Maintains | $120 → $124 | +9.33% | Oct 1, 2024 |
| Jefferies | Jefferies | Hold Reiterates $120 | Hold | Reiterates | $120 | +5.80% | Sep 26, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $131 | Buy | Initiates | $131 | +15.50% | Sep 19, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $112 → $120 | Strong Buy | Maintains | $112 → $120 | +5.80% | Aug 27, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $119 → $127 | Strong Buy | Maintains | $119 → $127 | +11.97% | Aug 22, 2024 |
Financial Forecast
Revenue This Year
42.15B
from 40.11B
Increased by 5.09%
Revenue Next Year
45.25B
from 42.15B
Increased by 7.35%
EPS This Year
4.71
from 3.26
Increased by 44.39%
EPS Next Year
5.19
from 4.71
Increased by 10.36%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 44.0B | 47.7B | 51.7B | ||
| Avg | 42.2B | 45.3B | 48.7B | ||
| Low | 40.7B | 43.5B | 46.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.7% | 13.2% | 14.1% | ||
| Avg | 5.1% | 7.4% | 7.5% | ||
| Low | 1.5% | 3.1% | 2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.96 | 5.59 | 6.28 | ||
| Avg | 4.71 | 5.19 | 5.68 | ||
| Low | 4.54 | 4.96 | 4.51 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 52.0% | 18.7% | 20.9% | ||
| Avg | 44.4% | 10.4% | 9.3% | ||
| Low | 39.2% | 5.3% | -13.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.